Rabeprazole Sodium Delayed-release
Product Images NDC 72834-210

2 FDA label images from Sarras Health, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium Delayed-release (NDC 72834-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sarras Health, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rabeprazole 01)

Chemical Structure (Rabeprazole 01)
Chemical structure diagram of rabeprazole sodium, the active ingredient in rabeprazole sodium delayed-release tablets from Sarras Health, LLC. The structure shows rings, sulfur, sodium, oxygen, nitrogen, and other atoms as part of the molecule.*
FDA Label Image

10 mg Bottle Label (Rabeprazole 02)

10 mg Bottle Label (Rabeprazole 02)
Label for Rabeprazole Sodium Delayed Release Capsules (Sprinkle) 10 mg by Sarras Health, LLC. The label states the package contains 30 capsules and includes storage instructions, cautionary notes about moisture protection, and directions for capsule use. It also shows the NDC 72834-210-30 and a barcode with serialization details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.